These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8399630)
1. Body composition and lipid abnormalities in hispanic and black patients on continuous ambulatory peritoneal dialysis. Henriquez MA; Gonzalez A; Bemis JA; Esquivel J Perit Dial Int; 1993; 13 Suppl 2():S424-7. PubMed ID: 8399630 [TBL] [Abstract][Full Text] [Related]
2. The uremic dyslipidemia: a cross-sectional and longitudinal study. Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199 [TBL] [Abstract][Full Text] [Related]
3. Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis. Yang X; Wang H; Zhu Z; Deng A J Tongji Med Univ; 1997; 17(2):126-8. PubMed ID: 9639806 [TBL] [Abstract][Full Text] [Related]
5. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis. Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232 [TBL] [Abstract][Full Text] [Related]
6. Is atherosclerosis accelerated by CAPD? Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197 [TBL] [Abstract][Full Text] [Related]
7. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445 [TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis]. Zwolińska D; Szprynger K Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806 [TBL] [Abstract][Full Text] [Related]
9. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250 [TBL] [Abstract][Full Text] [Related]
11. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa. Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030 [TBL] [Abstract][Full Text] [Related]
12. Body composition analysis of patients on waiting list for cadaveric renal transplantation: a comparison of hemodialysis and peritoneal dialysis patients. Bal Z; Uyar ME; Tutal E; Guliyev O; Sezer S; Haberal M Transplant Proc; 2013; 45(10):3489-93. PubMed ID: 24314939 [TBL] [Abstract][Full Text] [Related]
13. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients? Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M Kidney Int; 1990 Mar; 37(3):980-90. PubMed ID: 2313985 [TBL] [Abstract][Full Text] [Related]
15. Lipid abnormalities in black renal patients. Burrell DE; Antignani A; Goldwasser P; Mittman N; Fein PA; Slater PA; Gan A; Avram MM N Y State J Med; 1991 May; 91(5):192-6. PubMed ID: 1857570 [TBL] [Abstract][Full Text] [Related]
17. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis]. Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. Little J; Phillips L; Russell L; Griffiths A; Russell GI; Davies SJ J Am Soc Nephrol; 1998 Oct; 9(10):1931-9. PubMed ID: 9773795 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients. Burrell D; Antignani A; Fein PA; Goldwasser P; Mittman N; Avram MM ASAIO Trans; 1990; 36(3):M331-5. PubMed ID: 2123635 [TBL] [Abstract][Full Text] [Related]